期刊文献+
共找到108篇文章
< 1 2 6 >
每页显示 20 50 100
BDNF对H_2O_2诱导人肺癌细胞YTMLC-90凋亡的抑制效应 被引量:3
1
作者 陈建业 刘戟1 +5 位作者 王若菡 彭文珍 刘智敏 王晓明 陈海燕 陈俊杰 《癌症》 SCIE CAS CSCD 北大核心 2003年第9期938-942,共5页
背景与目的:已证实在神经系统内外多种细胞中均可合成神经营养因子,如神经生长因子(nervegrowthfactor,NGF)、脑源性神经营养因子(brainderivedneurotrophicfactor,BDNF)和神经营养素3/4(NT-3/4)。这些神经营养因子不仅能促进神经细胞... 背景与目的:已证实在神经系统内外多种细胞中均可合成神经营养因子,如神经生长因子(nervegrowthfactor,NGF)、脑源性神经营养因子(brainderivedneurotrophicfactor,BDNF)和神经营养素3/4(NT-3/4)。这些神经营养因子不仅能促进神经细胞的存活、增殖和凋亡,也与癌细胞侵犯神经组织的活性有关;但BDNF与肺癌细胞的生物学行为是否相关尚未见报道。本文旨在研究BDNF对过氧化氢(H2O2)诱导人肺癌细胞YTMLC-90凋亡的作用。方法:用含人I型胶原a1链(COLIA1)基因启动子和增强子元件及在其3'端接BDNFcDNA的微基因pSVCEPBFCAT,转染人肺癌细胞YTMLC-90并驱动BDNF异位表达,采用四甲基偶氮唑蓝(MTT)显色法检测细胞增殖,吖啶橙荧光染色显微镜和电镜观察细胞形态及其超微结构的改变,琼脂糖凝胶电泳检测染色质DNA断裂。结果:经200μmol/LH2O2作用24h,转染pSVCEPBFCAT的YTMLC-90细胞生长抑制率为30.0%,而未转染YTMLC-90和转染空载体pSVCEPCAT的YTMLC-90细胞生长抑制率分别为84.60%和80.00%,实验组与两个对照组之间的差异均有显著性(P<0.01);对照组YTMLC-90细胞可见凋亡特有的形态学及生物化学改变,如胞浆和核固缩、染色质断裂、DNA电泳呈梯状条带,而转染pSVCEPBFCAT的YTMLC-90细胞未发现上述凋亡特征。结论:BDNF促进YTMLC-90? 展开更多
关键词 BDNF H2O2 诱导 人肺癌细胞 ytmlc-90 抑制效应 细胞凋亡
下载PDF
苯丁酸钠体外对YTMLC-90细胞生长的影响 被引量:1
2
作者 朱莹 张灿珍 +1 位作者 朱岩 魏永越 《郑州大学学报(医学版)》 CAS 北大核心 2010年第3期493-495,共3页
目的:观察苯丁酸钠(PB)体外对人个旧肺鳞状细胞癌YTMLC-90细胞生长的影响。方法:YTMLC-90细胞分为6组,对照组不作任何处理,余5组分别给予250、500、1000、2000和4000mg/LPB,分别作用48、72和96h。采用MTT法观察各组细胞生长情况,计算细... 目的:观察苯丁酸钠(PB)体外对人个旧肺鳞状细胞癌YTMLC-90细胞生长的影响。方法:YTMLC-90细胞分为6组,对照组不作任何处理,余5组分别给予250、500、1000、2000和4000mg/LPB,分别作用48、72和96h。采用MTT法观察各组细胞生长情况,计算细胞生长抑制率。另取YTMLC-90细胞分为3组:对照组、500和1000mg/LPB组,分别作用48和72h,采用流式细胞术检测3组细胞的细胞周期及凋亡情况。结果:不同质量浓度的PB作用48、72和96h,各组细胞的生长抑制率相比,差异均有统计学意义(F=672.413、1633.321和1196.548,P均<0.05)。PB作用48和72h后,各组细胞G0/G1期、S期与G2/M期细胞百分率及凋亡率比较,差异均有统计学意义(F48h=508.347、224.522、19.890和111.849,F72h=311.979、102.923、247.432和177.018,P均<0.05)。与对照组相比,PB作用后YTMLC-90细胞生长缓慢,细胞阻滞于G0/G1期,凋亡增加(P<0.05)。结论:PB可抑制YTMLC-90细胞的生长,使其阻滞于G0/G1期,凋亡增加。 展开更多
关键词 苯丁酸钠 ytmlc-90细胞 生长 体外
下载PDF
KISS-1基因对人肺鳞状细胞癌细胞YTMLC-90增殖及侵袭能力的影响 被引量:3
3
作者 赵彬 王俊然 郑素琴 《中国医药》 2018年第1期48-50,共3页
目的探讨肿瘤转移抑制基因KISS-1对人肺鳞状细胞癌细胞YTMLC-90增殖及侵袭能力的影响。方法通过基因转染技术,将携带KISS-1基因的pEGFP-N2-KISS-1质粒转染入人YTMLC-90细胞,同时设不携带KISS-1基因的空质粒转染组和空白对照组作为对照,... 目的探讨肿瘤转移抑制基因KISS-1对人肺鳞状细胞癌细胞YTMLC-90增殖及侵袭能力的影响。方法通过基因转染技术,将携带KISS-1基因的pEGFP-N2-KISS-1质粒转染入人YTMLC-90细胞,同时设不携带KISS-1基因的空质粒转染组和空白对照组作为对照,用蛋白质印迹法检测转染后YTMLC-90细胞中KISS-1蛋白的表达以确定转染是否成功;噻唑蓝(MTT)法测定3组YTMLC-90细胞增殖情况;Millicell小室法检测3组YTMLC-90细胞的侵袭能力。结果成功将KISS-1基因转染入YTMLC-90细胞。pEGFP-N2-KISS-1质粒转染组YTMLC-90细胞的增殖活性与空质粒转染组和空白对照组差异无统计学意义(P>0.05),但YTMLC-90细胞穿透Millicell聚碳酸酯膜的细胞数较空质粒转染组和空白对照组明显减少[(35±5)×10~5个比(82±6)×10~5个、(84±5)×10~5个],差异有统计学意义(P<0.05)。结论 KISS-1基因对YTMLC-90细胞的增殖能力没有影响,但对其侵袭能力有抑制作用,提示KISS-1基因能够抑制肺癌的侵袭。 展开更多
关键词 肺肿瘤 ytmlc-90细胞 KISS-1基因 基因转染
下载PDF
Down-regulation of Hsp90 could change cell cycle distribution and increase drug sensitivity of tumor cells 被引量:21
4
作者 Liu XL Xiao B +5 位作者 Yu ZC Guo JC Zhao QC Xu L Shi YQ Fan DM 《World Journal of Gastroenterology》 SCIE CAS CSCD 1999年第3期199-208,共10页
AIM:To construct Hsp90 antisense RNA eukaryotic expression vector, transfect it into SGC7901 and SGC7901/VCR of MDR-type human gastric cancer cell lines, HCC7402 of human hepatic cancer and Ec109 of human esophageal c... AIM:To construct Hsp90 antisense RNA eukaryotic expression vector, transfect it into SGC7901 and SGC7901/VCR of MDR-type human gastric cancer cell lines, HCC7402 of human hepatic cancer and Ec109 of human esophageal cancer cell lines, and to study the cell cycle distribution of the gene transected cells and their response to chemotherapeutic drugs.METHODS:A 1.03kb cDNA sequence of Hsp90beta was obtained from the primary plasmid phHSP90 by EcoR I and BamH I nuclease digestion and was cloned to the EcoR I and BamH I site of the pcDNA by T4DNA ligase and an antisense orientation of Hsp90beta expression vector was constructed. The constructs were transfected with lipofectamine and positive clones were selected with G418. The expression of RNA was determined with dot blotting and RNase protection assay, and the expression of Hsp90 protein determined with western blot. Cell cycle distribution of the transfectants was analyzed with flow cytometry, and the drug sensitivity of the transfectants to Adriamycin (ADR), vincrinstine (VCR), mitomycin (MMC) and cyclophosphamide (CTX) with MTT and intracellular drug concentration of the transfectants was determined with flow cytometry.RESULTS:In EcoR I and BamH I restriction analysis, the size and the direction of the cloned sequence of Hsp90beta remained what had been designed and the gene constructs were named pcDNA-Hsp90.AH-SGC7901, AH-SGC7901/VCR, AH-HCC7402 and AH-Ec109 cell clones all expressed Hsp90 anti-sense RNA. The expression of Hsp90 was down-regulated in AH-SGC7901, AH-SGC7901/VCR, AH-HCC7402 and AH-Ec109 cell clones. Cell cycle distribution was changed differently. In AH-SGC7901/VCR and AH-Ec109 cells, G(1) phase cells were increased; S phase and G(2) phase cells were decreased as compared with their parental cell lines. In AH-SGC7901 cell, G(1)phase cells were decreased, G(2) phase cells increased and S phase cells were not changed, and in AH-HCC7402 cells G(1), S and G(2) phase cells remained unchanged as compared with their parental cell lines. The sensitivity of AH-SGC7901, AH-SGC7901/VCR, AH-HCC7402 and AH-Ec109 to chemotherapeutic drugs, the sensitivity of AH-SGC7901/VCR to ADR, VCR, MMC and CTX the sensitivity of AH-HCC7402 to ADR and VCR, and the sensitivity of Ec109 to ADR, VCR and CTX all increased as compared with their parental cell lines. The mean fluorescence intensity of ADR in AH-SGC7901, AH-SGC7901/VCR, AH-HCC7402 and AH-Ec109 was also significantly elevated (P 【 0.05).CONCLUSION: Down-regulation of Hsp90 could change cell cycle distribution and increase the drug sensitivity of tumor cells. 展开更多
关键词 SGC VCR HCC antisenseRNA Down-regulation of Hsp90 could change cell cycle distribution and increase drug sensitivity of tumor cells cell cycle
下载PDF
HSP90 and SIRT3 expression in hepatocellular carcinoma and their effect on invasive capability of human hepatocellular carcinoma cells 被引量:4
5
作者 Ming Gao Xiao-Ping Geng He-Ping Xiang 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第4期305-308,共4页
Objective:To vexplore expression of HSP90,SIRT3 in liver cancer tissue and its effect on liver cancer cell invasion ability.Methods:Moderate expression of HSP90 in SMMC-7721,HepG2,LO2 and Hep-3B cell lines were screen... Objective:To vexplore expression of HSP90,SIRT3 in liver cancer tissue and its effect on liver cancer cell invasion ability.Methods:Moderate expression of HSP90 in SMMC-7721,HepG2,LO2 and Hep-3B cell lines were screened,which was validated by RT-PCR.Overexpression of HSP90 cell line and lentivirus packaging HSP90-RNAi were established,which was validated by RT-PCR and western blot.The level of epithelial-mesenchymal transition(EMT)related gene was detected by western blot.The percentage of cancer stem cells was assayed by flow cytometry.Results:RT-PCR demonstrated the highest expression of HSP90mRNA in SMMC-7721 cells,the lowest expression of HSP90 mRNA in Hep3B and LO2 and the moderate expression of HSP90 mRNA in Hep-G2.Therefore,HepG2 was selected as a follow-up experiment cell lines.Compared with the blank control group,expression of HSP90in HSP overexpression group was increased obviously,and expression of HSP90 in HSP90shRNA group was significantly decreased,which indicated successful establishment of HSP overexpression and shRNA group.The apoptotic cell in hsp-siRNA group was higher than the blank control group,while the HSP overexpression group showed opposite results.Western blot results showed transfection HSP promoted cells EMT transformation,up-regulated the level of E-cadherin,and down-regulated the level of Vimentin;meanwhile,shRNA group showed opposite results.Conclusions:Carcinoma HepG2 cell transfeeted high expression of HSP can promote the transformation of EMT,improve the expression of Vimentin,reduce the expression of E-cadherin,and inhibit apoptosis of cancer stem cells,which improve the invasive ability of cancer of the liver cells.While hsp-siRNA group presents opposite results.In summary,the expression of HSP is closely related to the occurrence,development and invasion of cancer of the liver tissue. 展开更多
关键词 HSP90 SIRT3 EMT CANCER stem cell Liver CANCER
下载PDF
HSP90AA1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition 被引量:3
6
作者 FENGXIANG TANG YANSHI LI +5 位作者 MIN PAN ZHIHAI WANG TAO LU CHUAN LIU XIN ZHOU GUOHUA HU 《Oncology Research》 SCIE 2023年第5期787-803,共17页
Lymphatic metastasis(LM)emerges as an independent prognostic marker for hypopharyngeal squamous cell carcinoma(HSPSCC),chiefly contributing to treatment inefficacy.This study aimed to scrutinize the prognostic relevan... Lymphatic metastasis(LM)emerges as an independent prognostic marker for hypopharyngeal squamous cell carcinoma(HSPSCC),chiefly contributing to treatment inefficacy.This study aimed to scrutinize the prognostic relevance of HSP90AA1 and its potential regulatory mechanism of concerning LM in HPSCC.Methods:In a preceding investigation,HSP90AA1,a differential gene,was discovered through transcriptome sequencing of HPSCC tissues,considering both the presence and absence of LM.Validation of HSP90AA1 expression was accomplished via qRT-PCR,western-blotting(WB),and immunohistochemistry(IHC),while its prognostic significance was assessed employing Kaplan–Meier survival analysis(KMSA),log-rank test(LR),and Cox’s regression analysis(CRA).Bioinformatics techniques facilitated the prediction and analysis of its plausible mechanisms in LM,further substantiated by in vitro and in vivo experiments utilizing FaDu cell lines.Results:HSP90AA1 is substantially upregulated in HPSCC with LM and is identified as an independent prognostic risk determinant.The down-regulation of HSP90AA1 can achieve inhibition of tumor cell proliferation,migration and invasion.Both in vivo experiments and Bioinformatics exploration hint at promoting LM by Epithelial-mesenchymal transition(EMT),regulated by HSP90AA1.Conclusions:HSP90AA1,by controlling EMT,can foster LM in HPSCC.This finding sets the foundation for delving into new therapeutic targets for HPSCC. 展开更多
关键词 Hypopharyngeal squamous cell carcinoma Lymphatic metastasis HSP90AA1 EMT HNSCC
下载PDF
Transplantation of insulin-producing cells to treat diabetic rats after 90% pancreatectomy 被引量:2
7
作者 Ya-Bin Yu Jian-Min Bian Dian-Hua Gu 《World Journal of Gastroenterology》 SCIE CAS 2015年第21期6582-6590,共9页
AIM:To investigate the effects of transplantation of insulin-producing cells(IPCs) in the treatment of diabetic rats after 90% pancreatectomy.METHODS:Human umbilical cord mesenchymal stem cells(UCMSCs) were isolated a... AIM:To investigate the effects of transplantation of insulin-producing cells(IPCs) in the treatment of diabetic rats after 90% pancreatectomy.METHODS:Human umbilical cord mesenchymal stem cells(UCMSCs) were isolated and induced into IPCs using differentiation medium.Differentiated cells were examined by dithizone(DTZ) staining,reverse transcription-polymerase chain reaction(RT-PCR),and real-time RT-PCR.C-peptide release,both spontaneously and after glucose challenge,was measured by ELISA.IPCs were then transplanted into Sprague-Dawley rats after 90% pancreatectomy and blood glucose levels and body weight were measured.RESULTS:The differentiated cells were positive for DTZ staining and expressed pancreatic β-cell related genes.C-peptide release by the differentiated cells increased after glucose challenge(380.6 ± 15.32 pmol/L vs 272.4 ± 15.32 pmol/L,P < 0.05).Further,in the cell transplantation group,blood sugar levels were significantly lower than in the sham group 2 wk after transplantation(18.7 ± 2.5 mmol/L vs 25.8 ± 1.25 mmol/L,P < 0.05).Glucose tolerance tests showed that 45 min after intraperitoneal glucose injection,blood glucose levels were significantly lower on day 56 after transplantation of IPCs(12.5 ± 4.7 mmol/L vs 42.2 ± 9.3 mmol/L,P < 0.05).CONCLUSION:Our results show that UCMSCs can differentiate into islet-like cells in vitro under certain conditions,which can function as IPCs both in vivo and in vitro. 展开更多
关键词 Human UMBILICAL CORD MESENCHYMAL STEMcellS 90% PANCREATECTOMY Diabetic MELLITUS
下载PDF
Hsp90 inhibition induces destabilization of actin cytoskeleton in tumor cells:functional significance of Hsp90 interaction with F-actin
8
作者 Vishal Chaturvedi Amere Subbarao Sreedhar 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2010年第9期715-722,共8页
Objective:To examine the role of heat shock protein 90(Hsp90) in the maintenance of actin cytoskeleton in human neuroblastoma tumor cells.Methods:Co-precipitation experiments were performed to examine Hsp90 interactio... Objective:To examine the role of heat shock protein 90(Hsp90) in the maintenance of actin cytoskeleton in human neuroblastoma tumor cells.Methods:Co-precipitation experiments were performed to examine Hsp90 interaction with actin.Hsp90 and actin interactions were evaluated by protein refolding and acto-myosin motility assays.17-(AUylamino)-17- demethoxygeldanamycin(17AAG) induced actin-cytoskeleton re-organization was examined by laser scanning confocal microcopy.Results:It was shown that inhibition of Hsp90 by 17AAC accelerates detergent induced cell lysis of neuroblastoma tumor cells through destabilization of actin cytoskeleton.The in vitro co-precipitation experiments showed that functional but not mutant Hsp90 binds with F-actin.Among biochemical modifications,phopshorylation and oligomerization enhanced Hsp90 binding with F-actin.F-actin binding to Hsp90 interfered with Hsp90 chaperone activity in protein refolding assays,and Hsp90 binding to F-actin interfered with actin motility on myosin coated flow cell.In the combination treatment,17AAG irreversibly augmented the effect of cytochalasin D,an inhibitor of actin polymerization.Conclusions:It can be concluded that Hsp90 binds to F-actin in tumor cells and maintains the cellular integrity. The results display a novel element of Hsp90 inhibition in destabilizing the actin cytoskeleton of tumor cells,therefore suggest that 17AAG combination with cytoskeletal disruptor may be effective in combating cancer. 展开更多
关键词 HSP90 F-ACTIN CYTOSKELETON 17AAG Tumor cells Combination treatment
下载PDF
Identification of circulating CD90^+ CD73^+ cells in cirrhosis of liver
9
作者 Mitnala Sasikala Pugazhelthi Surya +5 位作者 Gaddipati Radhika Pondugala Pavan Kumar Mekala Subba Rao Rathindra Mohan Mukherjee Padaki Nagaraja Rao D Nageshwar Reddy 《World Journal of Stem Cells》 SCIE CAS 2011年第7期63-69,共7页
AIM:To identify circulating CD90 + CD73 + CD45 cells and evaluate their in vitro proliferating abilities.METHODS:Patients with cirrhosis(n=43),and healthy volunteers(n=40)were recruited to the study.Mononuclear cells ... AIM:To identify circulating CD90 + CD73 + CD45 cells and evaluate their in vitro proliferating abilities.METHODS:Patients with cirrhosis(n=43),and healthy volunteers(n=40)were recruited to the study.Mononuclear cells were isolated and cultured from the peripheral blood of controls and cirrhosis patients.Fibroblast-like cells that appeared in cultures were analyzed for morphological features,enumerated by flow cytometry and confirmed by immunocytochemistry(ICC).Colony forming efficiency(CFE)of these cells was assessed and expressed as a percentage.RESULTS:In comparison to healthy volunteers,cells obtained from cirrhotic patients showed a significantincrease(P<0.001)in the percentage of CD90+CD73+ CD45 cells in culture.Cultured cells also showed 10 fold increases in CFE.Flow cytometry and ICC confirmed that the proliferating cells expressed CD90 + CD73 + in the cultures from cirrhosis patients.CONCLUSION:These results indicate the presence of circulating CD90 + CD73 + CD45 cells in patients with liver cirrhosis that have the potential to proliferate at a higher rate. 展开更多
关键词 CD90+ CD73+ CD45 cellS LIVER CIRRHOSIS Proliferation Colony forming efficiency
下载PDF
PGK1-coupled HSP90 stabilizes GSK3βexpression to regulate the stemness of breast cancer stem cells
10
作者 Wei Tang Yu Wu +5 位作者 Xin Qi Rilei Yu Zhimin Lu Ao Chen Xinglong Fan Jing Li 《Cancer Biology & Medicine》 SCIE CAS CSCD 2022年第4期486-503,共18页
Objective:Glycogen synthase kinase-3β(GSK3β)has been recognized as a suppressor of Wnt/β-catenin signaling,which is critical for the stemness maintenance of breast cancer stem cells.However,the regulatory mechanism... Objective:Glycogen synthase kinase-3β(GSK3β)has been recognized as a suppressor of Wnt/β-catenin signaling,which is critical for the stemness maintenance of breast cancer stem cells.However,the regulatory mechanisms of GSK3βprotein expression remain elusive.Methods:Co-immunoprecipitation and mass spectral assays were performed to identify molecules binding to GSK3β,and to characterize the interactions of GSK3β,heat shock protein 90(Hsp90),and co-chaperones.The role of PGK1 in Hsp90 chaperoning GSK3βwas evaluated by constructing 293T cells stably expressing different domains/mutants of Hsp90α,and by performing a series of binding assays with bacterially purified proteins and clinical specimens.The influences of Hsp90 inhibitors on breast cancer stem cell stemness were investigated by Western blot and mammosphere formation assays.Results:We showed that GSK3βwas a client protein of Hsp90.Hsp90,which did not directly bind to GSK3β,interacted with phosphoglycerate kinase 1 via its C-terminal domain,thereby facilitating the binding of GSK3βto Hsp90.GSK3β-bound PGK1 interacted with Hsp90 in the“closed”conformation and stabilized GSK3βexpression in an Hsp90 activity-dependent manner.The Hsp90 inhibitor,17-AAG,rather than HDN-1,disrupted the interaction between Hsp90 and PGK1,and reduced GSK3βexpression,resulting in significantly reduced inhibition ofβ-catenin expression,to maintain the stemness of breast cancer stem cells.Conclusions:Our findings identified a novel regulatory mechanism of GSK3βexpression involving metabolic enzyme PGK1-coupled Hsp90,and highlighted the potential for more effective cancer treatment by selecting Hsp90 inhibitors that do not affect PGK1-regulated GSK3βexpression. 展开更多
关键词 Glycogen synthase kinase-3β(GSK3β) heat shock protein 90(Hsp90) phosphoglycerate kinase 1(PGK1) hsp90 inhibitors breast cancer stem cell
下载PDF
人脑髓鞘碱性蛋白对H_2O_2诱导人肺癌细胞YTLMC-90凋亡的抑制作用 被引量:9
11
作者 陈建业 王晓明 +5 位作者 刘戟 陈璟歆 王若菡 彭文珍 程汉华 陈俊杰 《癌症》 SCIE CAS CSCD 北大核心 2006年第2期170-174,共5页
背景与目的:人脑髓鞘碱性蛋白(myelinbasicprotein,MBP)广泛分布于神经系统及多种非神经组织之中,而且在肺癌、乳腺癌、神经胶质瘤等多种肿瘤细胞中均检查到MBP的表达。但MBP与癌细胞侵犯神经组织的活性是否相关、与肺癌细胞的生物学行... 背景与目的:人脑髓鞘碱性蛋白(myelinbasicprotein,MBP)广泛分布于神经系统及多种非神经组织之中,而且在肺癌、乳腺癌、神经胶质瘤等多种肿瘤细胞中均检查到MBP的表达。但MBP与癌细胞侵犯神经组织的活性是否相关、与肺癌细胞的生物学行为是否相关尚未见报道。本研究主要探讨MBP对过氧化氢(H2O2)诱导人肺癌细胞YTLMC-90凋亡的影响。方法:实验分为MBPcDNA微基因pSVCEPMBPCAT转染组(试验组)、空质粒pSVCEPCAT转染组和未转染组(对照组)。将含人Ⅰ型胶原a1链(COLⅠA1)基因启动子和增强子元件、并在其3′端接MBPcDNA的微基因,转染YTLMC-90细胞,并驱动MBP异位表达;采用MTT法检测细胞增殖,吖啶橙荧光染色显微镜和电镜观察细胞形态及其超微结构的改变;琼脂糖凝胶电泳检测染色质DNA断裂。结果:200μmol/LH2O2作用24h后,转染组、未转染组和空载体pSVCEPCAT转染组YTLMC-90细胞的生长抑制率分别为36.67%、84.00%和78.67%(P<0.001);对照组YTLMC-90细胞普遍可见凋亡细胞特有的形态学及生物化学改变,如胞核固缩、染色质断裂,DNA电泳呈梯状条带;而MBPcDNA微基因转染的YTLMC-90细胞未发现上述凋亡特征。结论:MBP促进YTLMC-90细胞增殖和拮抗H2O2诱导的凋亡,明显减少H2O2对YTLMC-90的细胞毒作用。 展开更多
关键词 髓鞘碱性蛋白 微基因 过氧化氢 肺肿瘤 YTLMC-90细胞系 凋亡
下载PDF
改良DAL-HX83/90和JLSG-96方案治疗儿童朗格汉斯细胞组织细胞增生症的疗效比较 被引量:4
12
作者 黄俊彬 江莉 +1 位作者 陈纯 薛红漫 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第4期1190-1195,共6页
目的:分析、比较不同化疗方案治疗儿童朗格汉斯细胞组织细胞增生症(Langerhans cell histiocytosis,LCH)的疗效和转归。方法:回顾性分析2005年1月至2014年12月间收治的31例LCH患儿的临床特点、疗效和转归,采用Kaplan-Meier方法分析改良D... 目的:分析、比较不同化疗方案治疗儿童朗格汉斯细胞组织细胞增生症(Langerhans cell histiocytosis,LCH)的疗效和转归。方法:回顾性分析2005年1月至2014年12月间收治的31例LCH患儿的临床特点、疗效和转归,采用Kaplan-Meier方法分析改良DAL-HX83/90组和JLSG-96组患儿的转归。31例LCH患儿中,男19例,女12例,年龄<2岁共12例,>2岁共19例;31例中最常见的是累及骨骼系统,共24例(占77.4%),其次为皮肤侵犯13例(42%)、肝脏9例(29.0%)、脾脏6例(19.4%)、血液系统4例(12.9%)。在31例LCH患儿中,初诊时16例发生误诊(占51.6%),主要误诊为:"上呼吸道感染"、"肿瘤"、"湿疹"等。结果:改良DAL-HX83/90方案的6周有效率为76.9%,JLSG-96方案的6周有效率为94.1%,组间比较未发现有统计学差异。JLSG-96方案组患儿1和3年生存率分别为100%和83.3%±15.2%,1和3年无病生存率分别为73.3%±11.4%和66.7%±12.2%;改良DAL-HX方案患儿1、3和5年总体生存率为70%±14.5%,1、3和5年无病生存率分别为50%±15.8%、40%±15.6%和26.7%±15%;两组患儿总生存时间和无病生存时间无显著性差异。结论:采用JLSG-96方案治疗儿童LCH可获得较好的疗效,并避免了依托泊苷带来的第二肿瘤风险。难治性LCH早期诊断、更细化的分组和延长维持治疗时间可能有助于提高无病生存率和减少复发。 展开更多
关键词 朗格汉斯细胞组织细胞增生症 JLSG-96方案 改良DAL-HX83/90方案 儿童
下载PDF
HSP90抑制剂17-DMAG对白血病细胞株K562增殖及凋亡的影响 被引量:1
13
作者 高风彩 郭荣 +3 位作者 田文亮 葛芳芳 孙玲 姜中兴 《中国实验血液学杂志》 CAS CSCD 北大核心 2017年第4期998-1002,共5页
目的:通过HSP90抑制剂17-二甲基胺乙基-17-去甲氧基格尔德霉素(17-DMAG)作用于白血病K562细胞株,观察HSP90在白血病K562细胞增殖与凋亡中的作用。方法:收集K562细胞,应用HSP90抑制剂17-DMAG作用于K562细胞株,通过半定量PCR检测HSP90的... 目的:通过HSP90抑制剂17-二甲基胺乙基-17-去甲氧基格尔德霉素(17-DMAG)作用于白血病K562细胞株,观察HSP90在白血病K562细胞增殖与凋亡中的作用。方法:收集K562细胞,应用HSP90抑制剂17-DMAG作用于K562细胞株,通过半定量PCR检测HSP90的基因表达,WST技术检测17-DMAG对细胞增殖的影响,Annexin V流式细胞术检测细胞凋亡。结果:17-DMAG处理K562细胞不同时间后,K562细胞的生长明显受抑,且呈时间依赖性(48 h)(r=0.9918)和剂量依赖性(3.2μmol/L)(r=0.9999)(P<0.01);不同浓度17-DMAG处理K562细胞不同时间后,K562细胞明显凋亡,且呈剂量依赖性(r=0.9903)(P<0.01);不同浓度17-DMAG作用于K562细胞48 h后,HSP90 mRNA表达明显减少,17-DMAG下调HSP90 mRNA的表达,且呈剂量依赖性(r=0.9227)(P<0.01)。结论:HSP90抑制剂17-DMAG能够抑制白血病K562细胞的增殖,诱导K562细胞凋亡,这为17-DMAG用于白血病的治疗提供实验依据。 展开更多
关键词 白血病 K562细胞 热休克蛋白90 17-DMAG 细胞增殖 细胞凋亡
下载PDF
“90增血剂”对特发性血小板减少性紫裥患者的T细胞亚群的作用 被引量:3
14
作者 李戈 刘爱菊 +1 位作者 严晓梁 郭晋蓉 《临床血液学杂志》 CAS 1992年第4期148-151,共4页
作者根据现代免疫学观点,自1989年起采用自制中药“90增血剂”治疗ITP46例。期间,应用间接免疫荧光技术检测了患者外周血T淋巴细胞亚群,结果表明病例组全T细胞(CD_3)、T辅助/诱导细胞(CD_4)降低,T抑制/细胞毒细胞(CD_8)增高,CD_4/CD_8... 作者根据现代免疫学观点,自1989年起采用自制中药“90增血剂”治疗ITP46例。期间,应用间接免疫荧光技术检测了患者外周血T淋巴细胞亚群,结果表明病例组全T细胞(CD_3)、T辅助/诱导细胞(CD_4)降低,T抑制/细胞毒细胞(CD_8)增高,CD_4/CD_8比值明显降低。治疗后,患者T亚群恢复常态,血小板数上升,骨髓产板型巨核细胞数增加,临床总有效率达91.2%,明显优于激素组(71.4%)。提示中药具有显著的疗效和良好的免疫调节作用。同时,动态观察ITP患者T细胞亚群的变化,对帮助临床判断治疗反应和预后有很大意义。 展开更多
关键词 90增血剂 紫癜 T细胞亚群
下载PDF
HSP70和HSP90α在人膀胱癌中的表达及意义 被引量:8
15
作者 唐伟 李家兵 《第三军医大学学报》 CAS CSCD 北大核心 2005年第6期560-562,共3页
目的 探讨热休克蛋白70(heat- shockprotein70,HSP70)和热休克蛋白90α(heat shockprotein90α,HSP90α)在 膀胱癌中的表达及临床意义。方法 应用免疫组化技术检测HSP70、HSP90α和增殖细胞核抗原(proliferatingcellnuclearan ti... 目的 探讨热休克蛋白70(heat- shockprotein70,HSP70)和热休克蛋白90α(heat shockprotein90α,HSP90α)在 膀胱癌中的表达及临床意义。方法 应用免疫组化技术检测HSP70、HSP90α和增殖细胞核抗原(proliferatingcellnuclearan tigen,PCNA)在50例膀胱癌组织和14例正常膀胱粘膜组织的表达。结果 膀胱癌中HSP70、HSP90α阳性表达率分别为 56%(28 50)和66%(33 50)。HSP70和HSP90α在膀胱癌病理分级、临床分期、生存率等方面具有显著性差异(P<0.05)。 HSP70、HSP90α和PCNA在膀胱癌中表达呈正相关。结论 HSP70、HSP90α与膀胱癌细胞分化,肿瘤的浸润深度有关,在膀 胱癌发生和发展中起重要作用。HSP70、HSP90α可以作为判断膀胱癌预后的新指标。 展开更多
关键词 HSP90Α HSP70 表达及 人膀胱癌 protein 热休克蛋白90Α 增殖细胞核抗原 膀胱癌组织 阳性表达率 显著性差异 癌细胞分化 临床意义 技术检测 免疫组化 cell 粘膜组织 病理分级 临床分期 PCNA 浸润深度 正相关 癌发生
下载PDF
HSP90抑制剂对缺氧诱导的RPE细胞SDF-1表达的影响 被引量:4
16
作者 王业青 张晓梅 +1 位作者 穆华 王巍 《眼科新进展》 CAS 北大核心 2009年第10期748-751,共4页
目的研究热休克蛋白(heat shock protein90,HSP90)抑制剂17-丙烯胺基-17-去甲氧基格尔德霉素(17-allylamino-17-demethoxygeldanamycin,17-AAG)对缺氧诱导的视网膜色素上皮(retinal pigment epithelial,RPE)细胞基质细胞衍生因子-1(stro... 目的研究热休克蛋白(heat shock protein90,HSP90)抑制剂17-丙烯胺基-17-去甲氧基格尔德霉素(17-allylamino-17-demethoxygeldanamycin,17-AAG)对缺氧诱导的视网膜色素上皮(retinal pigment epithelial,RPE)细胞基质细胞衍生因子-1(stro-malcell-derivedfactor-1,SDF-1)表达的影响。方法将培养的第3代RPE细胞分为缺氧对照组、DMSO对照组和17-AAG预处理组。其中17-AAG预处理组根据浓度不同又分为6组:0.01μmol.L-1、0.10μmol.L-1、0.50μmol.L-1、1.0μmol.L-1、5.0μmol.L-1、10.0μmol.L-1。利用氯化钴建立体外RPE细胞的化学缺氧模型,不同浓度的HSP90抑制剂17-AAG预处理RPE细胞1h后给予12h缺氧处理,RT-PCR和Westernblotting方法检测SDF-1表达变化情况。结果缺氧对照组、DMSO对照组和不同浓度17-AAG预处理组SDF-1mRNA与内参β-actinmRNA光密度比值分别为0.89±0.04、0.93±0.07、0.62±0.06、0.52±0.06、0.43±0.06、0.28±0.04、0.21±0.04、0.17±0.03;SDF-1蛋白与内参β-actin蛋白光密度比值分别为0.76±0.04、0.80±0.06、0.65±0.04、0.34±0.03、0.20±0.02、0.16±0.02、0.07±0.02、0.05±0.01。与缺氧对照组比较,DMSO对照组SDF-1mRNA和蛋白的表达无明显变化,而不同浓度17-AAG预处理组SDF-1mRNA和蛋白的表达明显降低(P均<0.05),呈浓度依赖性。结论HSP90的特异抑制剂17-AAG能有效抑制缺氧条件下RPE细胞SDF-1表达。 展开更多
关键词 基质细胞衍生因子-1 视网膜色素上皮 缺氧 热休克蛋白90
下载PDF
右美托咪定对宫颈癌细胞HSP90/ERK通路及顺铂敏感性的影响 被引量:5
17
作者 杨利利 胡强夫 +1 位作者 闵娜 王涛 《实用医学杂志》 CAS 北大核心 2022年第16期2019-2023,共5页
目的探讨右美托咪定对宫颈癌细胞热休克蛋白90(HSP90)/细胞外信号调节激酶(ERK通路及顺铂敏感性的影响。方法体外培养人宫颈癌HeLa细胞,分为对照组、顺铂组、低浓度组和高浓度组。蛋白印迹(Western blot)法检测各组HeLa细胞中HSP90、ERK... 目的探讨右美托咪定对宫颈癌细胞热休克蛋白90(HSP90)/细胞外信号调节激酶(ERK通路及顺铂敏感性的影响。方法体外培养人宫颈癌HeLa细胞,分为对照组、顺铂组、低浓度组和高浓度组。蛋白印迹(Western blot)法检测各组HeLa细胞中HSP90、ERK、p-ERK、DNA甲基转移酶1(DNMT1)、DNA聚合酶δ催化亚基(POLD1)、增殖细胞核抗原(PCNA)、Bcl-2相关X蛋白(Bax)蛋白表达情况;CCK-8法检测各组HeLa细胞增殖情况;流式细胞仪检测各组HeLa细胞凋亡情况。结果与对照组相比,顺铂组HeLa细胞中HSP90、p-ERK/ERK、DNMT1、POLD1、PCNA蛋白水平、OD值降低(P<0.05),而凋亡率、Bax蛋白水平升高(P<0.05);随着右美托咪定的添加及浓度的升高,HeLa细胞中HSP90、p-ERK/ERK、DNMT1、POLD1、PCNA蛋白水平、OD值依次降低(P<0.05),而凋亡率、Bax蛋白水平依次升高(P<0.05)。结论右美托咪定可抑制宫颈癌HeLa细胞中HSP90/ERK通路,增强HeLa细胞对顺铂的敏感性。 展开更多
关键词 右美托咪定 宫颈癌细胞 热休克蛋白90/细胞外信号调节激酶通路 顺铂敏感性
下载PDF
体硅90nm SRAM重离子单粒子多位翻转实验和数值模拟 被引量:4
18
作者 罗尹虹 张凤祁 +2 位作者 郭红霞 陈伟 丁李利 《现代应用物理》 2017年第1期48-55,共8页
建立了单粒子多位翻转的测试方法和数据处理方法,在此基础上开展了体硅90nm SRAM重离子单粒子多位翻转的实验研究。通过分析单粒子多位翻转百分比、均值、尺寸等参数随线性能量转移(linear energy transfer,LET)的变化关系,表明了纳米... 建立了单粒子多位翻转的测试方法和数据处理方法,在此基础上开展了体硅90nm SRAM重离子单粒子多位翻转的实验研究。通过分析单粒子多位翻转百分比、均值、尺寸等参数随线性能量转移(linear energy transfer,LET)的变化关系,表明了纳米尺度下器件单粒子多位翻转的严重性,指出了单粒子多位翻转对现有重离子单粒子效应实验方法和预估方法带来的影响。构建了包含多个存储单元的全三维器件模型,数值模拟研究了不同阱接触布放位置对单粒子多位翻转电荷收集的影响机制,表明阱电势扰动触发多单元双极放大机制是导致单粒子多位翻转的主要因素,减小阱接触与存储单元之间的距离是降低单粒子多位翻转的有效方法。 展开更多
关键词 90nm SRAM 单粒子多位翻转 阱电势扰动 寄生双极放大
下载PDF
HSP 90与survivin在人乳腺癌细胞中的作用及机制探讨 被引量:4
19
作者 余畅 邓华瑜 《肿瘤》 CAS CSCD 北大核心 2007年第10期791-794,共4页
目的:研究热激蛋白90(heat shock protein 90,HSP 90)和survivin在人乳腺癌细胞中的相互作用以及对肿瘤细胞增殖、凋亡的影响。方法:以人乳腺癌细胞MDA-MB-231为研究对象,用HSP 90抑制剂格尔德霉素(geldanamycin,GA)处理后,Western印迹... 目的:研究热激蛋白90(heat shock protein 90,HSP 90)和survivin在人乳腺癌细胞中的相互作用以及对肿瘤细胞增殖、凋亡的影响。方法:以人乳腺癌细胞MDA-MB-231为研究对象,用HSP 90抑制剂格尔德霉素(geldanamycin,GA)处理后,Western印迹法检测细胞中P-STAT3、survivin蛋白表达的变化;RT-PCR检测survivin mRNA的变化;MTT法检测其对细胞的增殖活性影响;流式细胞术检测凋亡的变化。结果:HSP90抑制剂GA可使人乳腺癌细胞MDA-MB-231中P-STAT3减少、survivin的蛋白表达减少,细胞的增殖活性降低,凋亡增多。结论:在MDA-MB-231细胞中,HSP 90可能通过激活JAK-STAT3信号通路,影响survivin转录表达,共同促进该肿瘤细胞的高增殖、低凋亡的恶性行为。 展开更多
关键词 乳腺肿瘤 热休克蛋白质类90 信号转导 SURVIVIN 格尔德霉素 MDA-MB-231细胞
下载PDF
狼疮肾炎患者热休克蛋白90及其亚型mRNA表达的研究 被引量:3
20
作者 李久宏 韩世新 +2 位作者 高奎斌 耿龙 宋芳吉 《中国麻风皮肤病杂志》 2005年第1期1-3,共3页
目的 : 探讨热休克蛋白 90及其亚型与狼疮肾炎患者发病与治疗之间的关系。方法 : 采用RT -PCR方法对 2 8例狼疮肾炎患者外周血单个核细胞中热休克蛋白 90及热休克蛋白 90α、热休克蛋白90 βmRNA进行了检测。结果 : 狼疮肾炎患者热... 目的 : 探讨热休克蛋白 90及其亚型与狼疮肾炎患者发病与治疗之间的关系。方法 : 采用RT -PCR方法对 2 8例狼疮肾炎患者外周血单个核细胞中热休克蛋白 90及热休克蛋白 90α、热休克蛋白90 βmRNA进行了检测。结果 : 狼疮肾炎患者热休克蛋白 90mRNA表达水平明显高于正常对照组 ,三组狼疮肾炎患者热休克蛋白 90α、90 βmRNA表达水平亦升高 ,糖皮质激素抵抗组升高水平较明显。 结论 : 热休克蛋白 90、90α和 90 βmRNA表达水平的升高可能与狼疮肾炎的发病有关 。 展开更多
关键词 狼疮肾炎 患者 热休克蛋白90Α MRNA表达 治疗 亚型 升高 发病 糖皮质激素 对照组
下载PDF
上一页 1 2 6 下一页 到第
使用帮助 返回顶部